Viewing Study NCT03431038



Ignite Creation Date: 2024-05-06 @ 11:06 AM
Last Modification Date: 2024-10-26 @ 12:40 PM
Study NCT ID: NCT03431038
Status: UNKNOWN
Last Update Posted: 2018-02-23
First Post: 2018-02-07

Brief Title: Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH
Sponsor: Beijing Tsinghua Chang Gung Hospital
Organization: Beijing Tsinghua Chang Gung Hospital

Study Overview

Official Title: Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH
Status: UNKNOWN
Status Verified Date: 2018-02
Last Known Status: ACTIVE_NOT_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study explore AAA prevalence in OSAHS patients by ultrasound screening and try to analysis risk factors of AAA in OSAHS patients
Detailed Description: Abdominal aortic aneurysm AAA is an extremely high mortality disease and ultrasound has been recommended for the screening of AAA which is highly sensitive and specific Studies have shown that screening for AAA in the population can significantly reduce deaths from ruptured abdominal aortic aneurysms However those study mainly focus on cardiovascular disease patients or general population no previous study target on obstructive sleep apnea hypopnea syndrome OSAHS population Retrospective studies show that the incidence of apnea syndrome in patients with abdominal aortic aneurysm is higher than that in the control group which suggests that OSAHS may be one of the causes of abdominal aortic aneurysm At present there is no relevant research on the screening of AAA in OSAHS population

The main objective of this study was to screen the prevalence of AAA in OSAHS population by a cross-sectional study

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None